I'm on the side of waiving some safeguards for clinical trials of
speculative newer drugs if patients are out of options.

On Mon, Mar 30, 2020 at 2:02 AM Rick Knoble via Mercedes <
mercedes@okiebenz.com> wrote:

> Posted for insight, not to incite.
>
>
> https://www.politico.com/news/2020/03/29/fda-emergency-authorization-anti-malaria-drug-155095
>
> Rick
> _______________________________________
> http://www.okiebenz.com
>
> To search list archives http://www.okiebenz.com/archive/
>
> To Unsubscribe or change delivery options go to:
> http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com
>
>
_______________________________________
http://www.okiebenz.com

To search list archives http://www.okiebenz.com/archive/

To Unsubscribe or change delivery options go to:
http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com

Reply via email to